RadNet will acquire Gleamer for up to $270 million, aiming to make DeepHealth the largest global provider of radiology clinical AI solutions.
Key Details
- 1RadNet acquires Paris-based AI firm Gleamer for up to $270 million.
- 2Gleamer serves over 700 customers across 44 countries, with FDA-cleared solutions for musculoskeletal, breast, lung, and brain imaging.
- 3The combined entity aims to become the largest provider of radiology clinical AI solutions globally.
- 4Gleamer's portfolio spans X-ray, mammography, CT, and MRI, and its products have analyzed over 30 million exams at more than 2,250 locations.
- 5Gleamer is expected to reach $30 million in annual recurring revenue in 2024, with compound annual growth over 90% from 2022–2025.
Why It Matters
This acquisition positions RadNet and its DeepHealth subsidiary as a leader in AI-driven radiology, further driving consolidation and innovation in imaging AI. The move underscores the growing demand for robust, FDA-cleared AI solutions across multiple imaging modalities.
Source
Radiology Business
Related News
•Radiology Business
Lucida Medical Raises $11M for AI-Based Prostate MRI Diagnosis Expansion
Lucida Medical, specializing in AI-assisted prostate cancer diagnosis via MRI, raises $11.4M to drive US FDA approval and platform expansion.
•Radiology Business
NYC Health + Hospitals CEO Considers AI to Replace Radiologists
NYC Health + Hospitals CEO suggests AI could partially replace radiologists, pending regulatory approval.
•AuntMinnie
AI Models Reveal Racial Disparities in Breast Cancer Patterns
Machine learning models reveal significant racial disparities and key predictors in breast cancer incidence across diverse groups.